GREAT POINT PARTNERS LLC

Holdings History for Neurogene Inc. - Common Stock, $0.000001 par value (NGNE)

Symbol: NGNE on Nasdaq
Investment type: Equity / Common Stock, $0.000001 par value
Latest Disclosed Shares Owned: 442,761 shares
Security Ownership %: 3%

Shares, Excluding Options vs Price

Value, Excluding Options

Great Point Partners, LLC ownership in Neurogene Inc. Common Stock, $0.000001 par value (NGNE)

14 Feb 2025 - Great Point Partners, LLC has filed an SCHEDULE 13G/A form with the Securities and Exchange Commission (SEC) disclosing ownership of 442,761 shares of Neurogene Inc. Common Stock, $0.000001 par value (NGNE). This represents 3% ownership of the company. This is the first filing by GREAT POINT PARTNERS LLC disclosing ownership of Neurogene Inc. Common Stock, $0.000001 par value (NGNE).

Reporting Name	Ownership %	Change	Value $	Shares owned	Change	Activity %	Price	Form	Report date	Filing time
Great Point Partners, LLC	3%		$6,822,947	442,761			$15.41	13G/A	31 Dec 2024	14 Feb 2025, 16:31

Holdings date	Weight	Change	Value $	Shares	Change	Activity %	Price	All Holders
31 Dec 2025	2.3%	-0.65%	$7,210,000	350,000	-96,814	-22%	$20.60	Q4 2025
30 Sep 2025	3.2%	-0.28%	$7,743,287	446,814	-39,045	-8%	$17.33	Q3 2025
30 Jun 2025	4.7%	+0.14%	$7,263,592	485,859	+14,895	+3.2%	$14.95	Q2 2025
31 Mar 2025	3%	+0.18%	$5,514,988	470,964	+28,203		$11.71	Q1 2025
31 Dec 2024	4.8%	-6%	$10,121,516	442,761	-561,530	-56%	$22.86	Q4 2024
30 Sep 2024	13%	0%	$42,140,050	1,004,291	0		$41.96	Q3 2024
30 Jun 2024	7%	0%	$36,546,149	1,004,291	0		$36.39	Q2 2024
31 Mar 2024	8%	+0.08%	$51,118,412	1,004,291	+10,062	+1%	$50.90	Q1 2024
31 Dec 2023	3.3%	+3.3%	$19,268,158	994,229	+994,229	NEW	$19.38	Q4 2023

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.